4.8 Editorial Material

Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens

期刊

CANCER CELL
卷 34, 期 2, 页码 181-183

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2018.07.008

关键词

-

资金

  1. Pancreatic Cancer Action Network-AACR Pathway to Leadership Program
  2. National Pancreas Foundation
  3. NIH/NHLBI [R01 HL128239]
  4. Department of Defense Bone Marrow Failure Research Program [W81XWH-16-1-0059]
  5. Starr Foundation [I8-A8-075]
  6. Henry & Marilyn Taub Foundation
  7. Edward P. Evans Foundation
  8. Leukemia and Lymphoma SocietyLeukemia and Lymphoma Society
  9. Pershing Square Sohn Cancer Research Alliance

向作者/读者索取更多资源

In this issue of Cancer Cell, Kahles et al. perform a comprehensive analysis of RNA splicing across cancer types and identify novel correlations between genetic alterations and splicing in cancer. In addition, they identify that tumor-specific splicing has the potential to generate a large new class of tumor-specific neoantigens.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据